ZOMEDICA CORP (ZOM)

CA98980M1095 - Common Stock

0.133  +0 (+2.23%)

After market: 0.1338 +0 (+0.6%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
4.133M18.93M
358.01%		25.186M
33.05%		34.441M
36.75%
EBITDA
YoY % growth
-20.228M
-24.60%		-17.881M
11.60%		-25.294M
-41.46%		N/AN/AN/A
EBIT
YoY % growth
-21.368M
-27.46%		-21.923M
-2.60%		-31.592M
-44.10%		-5.096M
83.87%
Operating Margin
-516.99%-115.81%-125.43%-14.80%
EPS
YoY % growth
N/AN/A-0.02-0.01
56.09%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		0.00
Revenue
Q2Q % growth		8.266M
50.78%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-1.223M
83.72%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.01
-66.67%		0.00-0.01-∞%
Q3 2023
Q2Q % growth		 0.00
80.00%		0.000.00-∞%
Q2 2023
Q2Q % growth		 -0.01 0.00-0.01-∞%
Q1 2023
Q2Q % growth		 -0.01 0.00-0.01-∞%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 7.337M
19.17%		7.07M267K3.78%
Q3 2023
Q2Q % growth		 6.347M
32.89%		8.368M-2.021M-24.15%
Q2 2023
Q2Q % growth		 6.02M
41.78%		7.413M-1.393M-18.79%
Q1 2023
Q2Q % growth		 5.482M
46.15%		6.696M-1.214M-18.13%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% N/A
Revenue0% 0% 0% -20.81%